Other hematologic malignancies
Breast and gynecologic cancers
MOA, mechanism of action; MOD, mechanism of disease.
This document contains information for healthcare providers and is intended solely for educational purposes. This display includes ongoing clinical trials for both approved and investigational compounds. Some agents are approved in select indications. Inclusion in this display does not imply regulatory approval for these compounds or all indications. Information about all trials can be found at www.clinicaltrials.gov. All clinical study information updated as of April 10, 2023.
©2023 GSK group of companies or its licensor. All rights reserved. NX-GBL-ON-OGM-230008. May 2023.